Search

Your search keyword '"Bolotin S"' showing total 335 results

Search Constraints

Start Over You searched for: Author "Bolotin S" Remove constraint Author: "Bolotin S"
335 results on '"Bolotin S"'

Search Results

151. A Call for Caution in Use of Pertussis Vaccine Effectiveness Studies to Estimate Waning Immunity: A Canadian Immunization Research Network Study.

152. A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study.

153. Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy.

154. Benefiting From Digital Use: Prospective Association of Internet Use With Knowledge and Preventive Behaviors Related to Alzheimer Disease in the Israeli Survey of Aging.

155. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.

156. Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort study.

157. Infant pertussis and maternal immunity: The curious case of Canada.

158. Normal forms and averaging in an acceleration problem in nonholonomic mechanics.

159. What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review.

161. The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review.

162. Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review.

163. Measles Antibody Levels in Young Infants.

164. Exploring indirect protection associated with influenza immunization - A systematic review of the literature.

165. Modernizing and Expanding the NASA Space Geodesy Network to Meet Future Geodetic Requirements.

166. The evolving nature of Bordetella pertussis in Ontario, Canada, 2009-2017: strains with shifting genotypes and pertactin deficiency.

167. Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada.

168. Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200.

169. Measles outbreaks demand systems-level action locally, nationally and globally.

171. Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.

172. Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

173. Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.

174. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

175. Assessing the severity of influenza: a role for longitudinal telephone surveys?

176. Under-reporting of pertussis in Ontario: A Canadian Immunization Research Network (CIRN) study using capture-recapture.

177. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.

178. Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.

179. Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocol.

180. The basic reproduction number (R 0 ) of measles: a systematic review.

181. The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.

182. Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada.

183. Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.

184. Effectiveness of pertussis vaccination and duration of immunity.

185. Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.

186. EPR spectroscopy solutions for assessment of decellularization of intrathoracic organs and tissues.

187. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

188. Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011.

189. Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity.

190. How and why researchers use the number needed to vaccinate to inform decision making--a systematic review.

191. Increased incidence of tuberculosis in zimbabwe, in association with food insecurity, and economic collapse: an ecological analysis.

192. A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period.

193. Highly active anti-retroviral therapy in the prevention of mother-to-child transmission of HIV in rural Zimbabwe during the socio-economic crisis.

194. Genotypic characterization of tuberculosis transmission within Toronto's under-housed population, 1997-2008.

195. The Ontario universal typing of tuberculosis (OUT-TB) surveillance program--what it means to you.

196. Verification of the Combimatrix influenza detection assay for the detection of influenza A subtype during the 2007-2008 influenza season in Toronto, Canada.

197. Validation of the TaqMan Influenza A Detection Kit and a rapid automated total nucleic acid extraction method to detect influenza A virus in nasopharyngeal specimens.

198. Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America.

199. On the origin of the treponematoses: a phylogenetic approach.

200. The two-component system sivS/R regulates virulence in Streptococcus iniae.

Catalog

Books, media, physical & digital resources